Ampio Pharmaceuticals Inc (AMPE)
0.2405
+0.02
(+6.89%)
USD |
OTCM |
May 07, 15:35
Ampio Pharmaceuticals Enterprise Value: -3.834M for May 6, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 06, 2024 | -3.834M |
| May 03, 2024 | -3.800M |
| May 02, 2024 | -3.803M |
| May 01, 2024 | -3.714M |
| April 30, 2024 | -3.804M |
| April 29, 2024 | -3.658M |
| April 26, 2024 | -3.724M |
| April 25, 2024 | -3.692M |
| April 24, 2024 | -3.692M |
| April 23, 2024 | -3.764M |
| April 22, 2024 | -3.702M |
| April 19, 2024 | -3.526M |
| April 18, 2024 | -3.814M |
| April 17, 2024 | -3.805M |
| April 16, 2024 | -3.748M |
| April 12, 2024 | -3.385M |
| April 11, 2024 | -3.281M |
| April 10, 2024 | -3.124M |
| April 09, 2024 | -3.090M |
| April 08, 2024 | -3.078M |
| April 05, 2024 | -3.131M |
| April 04, 2024 | -3.135M |
| April 03, 2024 | -3.043M |
| April 02, 2024 | -3.181M |
| April 01, 2024 | -3.188M |
| Date | Value |
|---|---|
| March 28, 2024 | -3.044M |
| March 27, 2024 | -3.158M |
| March 26, 2024 | -3.168M |
| March 25, 2024 | -2.182M |
| March 22, 2024 | -2.193M |
| March 21, 2024 | -2.159M |
| March 20, 2024 | -2.250M |
| March 19, 2024 | -2.261M |
| March 18, 2024 | -2.182M |
| March 15, 2024 | -2.238M |
| March 14, 2024 | -2.227M |
| March 13, 2024 | -2.193M |
| March 12, 2024 | -2.136M |
| March 11, 2024 | -2.068M |
| March 08, 2024 | -2.244M |
| March 07, 2024 | -2.318M |
| March 06, 2024 | -2.318M |
| March 05, 2024 | -2.295M |
| March 04, 2024 | -2.295M |
| March 01, 2024 | -2.227M |
| February 29, 2024 | -2.329M |
| February 28, 2024 | -1.478M |
| February 27, 2024 | -2.000M |
| February 26, 2024 | -1.966M |
| February 23, 2024 | -2.023M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-13.62M
Minimum
Dec 27 2022
501.43M
Maximum
Dec 22 2020
95.28M
Average
57.05M
Median
Enterprise Value Benchmarks
| NeuBase Therapeutics Inc | -11.02M |
| Tivic Health Systems Inc | -1.848M |
| Oragenics Inc | 3.261M |
| Actinium Pharmaceuticals Inc | 179.23M |
| MAIA Biotechnology Inc | 60.97M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.054M |
| Total Expenses (Quarterly) | 2.215M |
| EPS Diluted (Quarterly) | -2.48 |
| Earnings Yield | -4.58K% |
| Normalized Earnings Yield | -78584.64 |